{"id":"https://openalex.org/W2747377366","doi":"https://doi.org/10.1136/bjophthalmol-2017-310445","title":"Active surveillance of choroidal neovascularisation in children: incidence, aetiology and management findings from a national study in the UK","display_name":"Active surveillance of choroidal neovascularisation in children: incidence, aetiology and management findings from a national study in the UK","publication_year":2017,"publication_date":"2017-08-26","ids":{"openalex":"https://openalex.org/W2747377366","doi":"https://doi.org/10.1136/bjophthalmol-2017-310445","mag":"2747377366","pmid":"https://pubmed.ncbi.nlm.nih.gov/28844051"},"language":"en","primary_location":{"id":"doi:10.1136/bjophthalmol-2017-310445","doi":"https://doi.org/10.1136/bjophthalmol-2017-310445","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bjophthalmol-2017-310445","pdf_url":null,"source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://discovery.ucl.ac.uk/1572246/1/Mariya%20Moosajee%20BJO%20CNV%20Final%20revised%20Manuscript.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087017472","display_name":"Mariya Moosajee","orcid":"https://orcid.org/0000-0003-1688-5360","observed_orcids":["https://orcid.org/0000-0003-1688-5360"]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mariya Moosajee","raw_affiliation_strings":["Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK","UCL Institute of Ophthalmology, London, EC1V 9EL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]},{"raw_affiliation_string":"UCL Institute of Ophthalmology, London, EC1V 9EL, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061660167","display_name":"Alessandro Abbouda","orcid":"https://orcid.org/0000-0001-8582-4823","observed_orcids":["https://orcid.org/0000-0001-8582-4823"]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alessandro Abbouda","raw_affiliation_strings":["Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112562132","display_name":"B Foot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799665334","display_name":"Royal College of Ophthalmologists","ror":"https://ror.org/05s86pb97","country_code":"GB","type":"education","lineage":["https://openalex.org/I14746517","https://openalex.org/I157543744","https://openalex.org/I2799665334"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Barnaby Foot","raw_affiliation_strings":["British Ophthalmological Surveillance Unit, Royal College of Ophthalmologists, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"British Ophthalmological Surveillance Unit, Royal College of Ophthalmologists, London, UK","institution_ids":["https://openalex.org/I2799665334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069032977","display_name":"Catey Bunce","orcid":"https://orcid.org/0000-0002-0935-3713","observed_orcids":["https://orcid.org/0000-0002-0935-3713"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catey Bunce","raw_affiliation_strings":["Department of Ophthalmology, University of California, San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-0935-3713","affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, University of California, San Francisco, California, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106176057","display_name":"Anthony T. Moore","orcid":"https://orcid.org/0000-0001-7087-1205","observed_orcids":["https://orcid.org/0000-0001-7087-1205"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Anthony T Moore","raw_affiliation_strings":["Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","Department of Ophthalmology, UCSF School of Medicine, Koret Vision Center, San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Department of Ophthalmology, UCSF School of Medicine, Koret Vision Center, San Francisco, California, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025441287","display_name":"James F Acheson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210150574","display_name":"Moorfields Eye Hospital","ror":"https://ror.org/03tb37539","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Acheson","raw_affiliation_strings":["Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5087017472"],"corresponding_institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210150574","https://openalex.org/I45129253"],"apc_list":null,"apc_paid":null,"fwci":0.5344,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.64204374,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"102","issue":"4","first_page":"438","last_page":"443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9950000047683716},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.9570000171661377},{"id":"https://openalex.org/keywords/etiology","display_name":"etiology","score":0.9259999990463257},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/visual-outcome","display_name":"visual outcome","score":0.7070000171661377},{"id":"https://openalex.org/keywords/optic-disc-abnormalities","display_name":"optic disc abnormalities","score":0.6539999842643738},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9522820115089417},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.6827162504196167},{"id":"https://openalex.org/C137627325","wikidata":"https://www.wikidata.org/wiki/Q156318","display_name":"Etiology","level":2,"score":0.6424379348754883},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5991860628128052},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5765633583068848},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5740580558776855},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5389133095741272},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4913281500339508},{"id":"https://openalex.org/C2780248432","wikidata":"https://www.wikidata.org/wiki/Q1434206","display_name":"Fluorescein angiography","level":3,"score":0.4857054650783539},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.47997307777404785},{"id":"https://openalex.org/C2776391266","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Fundus (uterus)","level":2,"score":0.4373336732387543},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.41418182849884033},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33782216906547546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14474070072174072},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08559831976890564},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/bjophthalmol-2017-310445","doi":"https://doi.org/10.1136/bjophthalmol-2017-310445","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bjophthalmol-2017-310445","pdf_url":null,"source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:28844051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28844051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of ophthalmology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1572246","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1572246/","pdf_url":"https://discovery.ucl.ac.uk/1572246/1/Mariya%20Moosajee%20BJO%20CNV%20Final%20revised%20Manuscript.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Ophthalmology , 102 (4) pp. 438-443. (2018)","raw_type":"Article"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:102/4/438","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/102/4/438","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1572246","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1572246/","pdf_url":"https://discovery.ucl.ac.uk/1572246/1/Mariya%20Moosajee%20BJO%20CNV%20Final%20revised%20Manuscript.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Ophthalmology , 102 (4) pp. 438-443. (2018)","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1880760028","display_name":null,"funder_award_id":"CL-2011-18-010","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320188","display_name":"Fight for Sight UK","ror":"https://ror.org/03133qe46"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2747377366.pdf","grobid_xml":"https://content.openalex.org/works/W2747377366.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W132038692","https://openalex.org/W180889058","https://openalex.org/W1984858954","https://openalex.org/W1985075172","https://openalex.org/W1986614017","https://openalex.org/W2001061080","https://openalex.org/W2005065584","https://openalex.org/W2013370259","https://openalex.org/W2014075460","https://openalex.org/W2042894155","https://openalex.org/W2043672484","https://openalex.org/W2045031447","https://openalex.org/W2046755321","https://openalex.org/W2051942377","https://openalex.org/W2058266372","https://openalex.org/W2060986097","https://openalex.org/W2066542803","https://openalex.org/W2073500557","https://openalex.org/W2091887954","https://openalex.org/W2113170046","https://openalex.org/W2124199139","https://openalex.org/W2129168609","https://openalex.org/W2195657833","https://openalex.org/W2318076598","https://openalex.org/W2397594800","https://openalex.org/W2406524944","https://openalex.org/W2466212705"],"related_works":["https://openalex.org/W3194502913","https://openalex.org/W4401799937","https://openalex.org/W4409897984","https://openalex.org/W2051942377","https://openalex.org/W3216833555","https://openalex.org/W2013370259","https://openalex.org/W4393998316","https://openalex.org/W3172798699","https://openalex.org/W2466212705","https://openalex.org/W4405460368"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"To":[1],"determine":[2],"the":[3,28,216,240],"UK":[4,61],"incidence,":[5],"demographics,":[6],"aetiology,":[7],"management":[8],"and":[9,36,69,120,131,157,163,167,206,239],"visual":[10,197,233],"outcome":[11],"for":[12,65],"children":[13,44,55,103,173],"developing":[14],"choroidal":[15],"neovascularisation":[16],"(CNV).":[17],"METHODS:":[18],"A":[19],"prospective":[20,219],"population-based":[21,218],"observational":[22],"study":[23,220],"of":[24,148,160,180,221,236,242],"routine":[25],"practice":[26],"via":[27],"British":[29],"Ophthalmological":[30],"Surveillance":[31],"Unit":[32],"between":[33],"January":[34],"2012":[35],"December":[37],"2013":[38],"with":[39,49,56,174,185,230],"subsequent":[40],"1-year":[41,210],"follow-up":[42,211],"in":[43,128,135,171,199,223],"under":[45,70],"16":[46,68],"years":[47,86],"old":[48],"newly":[50],"diagnosed":[51],"CNV.":[52],"RESULTS:":[53],"Twenty-seven":[54],"CNV":[57,222,237],"were":[58,92,99],"reported.":[59],"The":[60,81,108,177,192],"estimated":[62],"annual":[63],"incidence":[64],"those":[66],"aged":[67],"was":[71,84,126,183,201],"0.21":[72],"per":[73,95],"100":[74],"000":[75],"(95%":[76],"CI":[77],"0.133":[78],"to":[79],"0.299).":[80],"mean":[82,178,193],"age":[83],"11.1":[85],"(SD":[87],"3.9,":[88],"range":[89],"4-16).":[90],"Fourteen":[91],"female.":[93],"Seventy-seven":[94],"cent":[96],"(22":[97],"patients)":[98],"Caucasian":[100],"British.":[101],"Twenty-three":[102],"(85%)":[104],"had":[105],"unilateral":[106],"disease.":[107],"most":[109],"common":[110],"aetiology":[111],"included":[112,138],"inflammatory":[113,175],"retinochoroidopathy":[114],"(n=9),":[115],"optic":[116],"disc":[117],"abnormalities":[118],"(n=9)":[119],"idiopathic":[121],"(n=5).":[122],"Optical":[123],"coherence":[124],"tomography":[125],"performed":[127],"all":[129],"cases":[130],"fundus":[132],"fluorescein":[133],"angiography":[134],"61%.":[136],"Management":[137],"observation":[139],"only":[140,189],"(n=10),":[141],"anti-vascular":[142],"endothelial":[143],"growth":[144],"factor":[145],"(anti-VEGF)":[146],"injection":[147],"bevacizumab":[149],"(n=14)":[150],"or":[151,154],"ranibizumab":[152],"(n=2),":[153],"both":[155],"(n=1),":[156],"additional":[158],"use":[159,241],"oral":[161],"(n=1)":[162],"local":[164],"(periocular":[165],"n=2":[166],"intravitreal":[168],"n=2)":[169],"steroids":[170],"five":[172],"retinochoroidopathy.":[176],"number":[179],"anti-VEGF":[181,243],"injections":[182],"2\u00b11,":[184],"eight":[186],"patients":[187],"receiving":[188],"one":[190],"injection.":[191],"(SD)":[194],"best":[195],"corrected":[196],"acuity":[198],"LogMAR":[200],"0.91":[202],"(0.53)":[203,208],"at":[204,209],"presentation":[205],"0.74":[207],"(p=0.09).":[212],"CONCLUSION:":[213],"This":[214,225],"is":[215,226],"first":[217],"children.":[224],"a":[227,231],"rare":[228],"disorder":[229],"poor":[232],"prognosis":[234],"irrespective":[235],"location":[238],"therapy.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-08-31T00:00:00"}